CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,573,792 | -35.5% | 476,800 | -25.8% | 0.01% | -33.3% |
Q2 2023 | $8,641,839 | +97.3% | 642,994 | +143.4% | 0.02% | +80.0% |
Q1 2023 | $4,380,834 | +3.1% | 264,224 | +15.7% | 0.01% | 0.0% |
Q4 2022 | $4,248,798 | -17.3% | 228,430 | -43.0% | 0.01% | -23.1% |
Q3 2022 | $5,140,000 | +50.4% | 400,631 | -17.8% | 0.01% | +62.5% |
Q2 2022 | $3,418,000 | -0.3% | 487,541 | +17.9% | 0.01% | +14.3% |
Q1 2022 | $3,428,000 | +15.6% | 413,552 | -5.6% | 0.01% | +40.0% |
Q4 2021 | $2,966,000 | +17.7% | 438,073 | -7.8% | 0.01% | 0.0% |
Q3 2021 | $2,519,000 | +35.1% | 475,317 | +46.6% | 0.01% | +66.7% |
Q2 2021 | $1,864,000 | -44.1% | 324,198 | -55.2% | 0.00% | -40.0% |
Q1 2021 | $3,336,000 | +0.5% | 723,653 | -27.2% | 0.01% | -16.7% |
Q4 2020 | $3,318,000 | +31.5% | 993,431 | +16.9% | 0.01% | +50.0% |
Q3 2020 | $2,523,000 | -39.7% | 849,532 | -6.2% | 0.00% | -42.9% |
Q2 2020 | $4,182,000 | -10.4% | 905,244 | -25.3% | 0.01% | -12.5% |
Q1 2020 | $4,668,000 | +9.7% | 1,212,449 | +6.8% | 0.01% | +60.0% |
Q4 2019 | $4,257,000 | +381.6% | 1,135,144 | +581.5% | 0.01% | +400.0% |
Q3 2019 | $884,000 | -17.9% | 166,570 | -40.6% | 0.00% | 0.0% |
Q2 2019 | $1,077,000 | +237.6% | 280,438 | +348.0% | 0.00% | – |
Q1 2019 | $319,000 | +19.0% | 62,597 | -55.2% | 0.00% | – |
Q4 2018 | $268,000 | -64.3% | 139,842 | -29.6% | 0.00% | -100.0% |
Q3 2018 | $751,000 | -35.9% | 198,596 | -47.1% | 0.00% | 0.0% |
Q2 2018 | $1,171,000 | -38.9% | 375,396 | -53.2% | 0.00% | -50.0% |
Q1 2018 | $1,918,000 | +45.7% | 802,697 | +138.5% | 0.00% | +100.0% |
Q4 2017 | $1,316,000 | +48.0% | 336,578 | -4.6% | 0.00% | 0.0% |
Q3 2017 | $889,000 | +469.9% | 352,626 | +453.2% | 0.00% | – |
Q4 2015 | $156,000 | -62.8% | 63,742 | -54.3% | 0.00% | -100.0% |
Q3 2015 | $419,000 | -45.1% | 139,562 | -24.5% | 0.00% | -50.0% |
Q2 2015 | $763,000 | -4.6% | 184,782 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $800,000 | +27.8% | 184,782 | -12.4% | 0.00% | +100.0% |
Q4 2014 | $626,000 | -21.6% | 210,882 | -12.2% | 0.00% | -50.0% |
Q3 2014 | $798,000 | +31.2% | 240,282 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $608,000 | +33.6% | 240,282 | +19.4% | 0.00% | +100.0% |
Q1 2014 | $455,000 | +55.8% | 201,282 | +34.5% | 0.00% | 0.0% |
Q4 2013 | $292,000 | – | 149,682 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |